TTOO (T2 Biosystems Inc) Ratio of Long-Term Indebtedness to Capital

T2 Biosystems, Inc. (TTOO) focuses on MRI systems for rapid sepsis diagnostics, yet slow expansion into medical centers calls into question the return on software investments. This historical price chart links these risks to the technological advantage of T2MR, which enables the detection of bloodborne pathogens within hours. The indicator stands at 0.00, while the integration of panels in intensive care units guarantees multi-year demand for ancillary consumables.

This ratio determines the issuer's financial stability by analyzing the structure of its long-term liabilities. The metric compares the total amount of loans with a maturity of over one year against total equity. The trend of the long-term debt-to-equity ratio reflects the balance between leveraged expansion and financial autonomy. Analyzing this curve is critically important for T2 Biosystems, Inc. (TTOO). Innovations in rapid sepsis diagnostics require significant investments, which the company must effectively capitalize.